1. Anon. Hepatitis C – global prevalence (update). Weekly Epidemiology Record 1999; 74: 425–427.
2. Majid, A, et al. Molecular epidemiology of hepatitis C virus infection amongst intravenous drug users in rural communities. Journal of Medical Virology 1995; 46: 48–51.
3. Lamden, KH, et al. Hepatitis B and hepatitis C virus infections: Risk factors among drug users in North West England. Journal of Infection 1998; 17: 260–269.
4. Hope, V, et al. Prevalence of hepatitis C among injection drug users in England and Wales. Is harm reduction working? American Journal of Public Health 2001; 91: 38–42.
5. Hutchinson, SJ, et al. Prevalence of hepatitis C among injectors in Scotland 1989–2000; declining trends among young injectors halt in the late 1990s. Epidemiology and Infection 2002; 128: 473–477.
6. Soldan, K, Barbara, JAJ, Heptonstall, J. Incidence of seroconversion to positivity for hepatitis C antibody in repeat blood donors in England, 1993–5. British Medical Journal 1998; 316: 1413–1417.
7. Balogun, MA, et al. The prevalence and genetic diversity of hepatitis C infection in antenatal clinic attenders in two regions of England. Epidemiology and Infection 2000; 125: 705–712.
8. Ward, G, et al. Prevalence of hepatitis C among pregnant women attending an inner London obstetric department: uptake and acceptability of named antenatal testing. Gut 2000; 47: 277–280.
9. Goldberg, D, et al. Hepatitis C virus among high and low risk pregnant women in Dundee: unlinked anonymous testing. British Journal of Obstetrics and Gynaecology 2001; 108: 365–370.
10. Wreghitt, TG, et al. Transmission of hepatitis C virus by organ transplantation in the United Kingdom. Journal of Hepatology 1994; 20: 768–772.
11. Zuckerman, J, et al. Prevalence of hepatitis C antibodies in clinical health care workers. Lancet 1994; 343: 1618–1620.
12. HPA. Hepatitis C in England: The Health Protection Agency Annual Report 2007. London: Health Protection Agency Centre for Infections, December 2007.
13. Balogun, MA, et al. The prevalence of hepatitis C in England and Wales. Journal of Infection 2002; 45: 119–226.
14. Osborne, K, et al. Ten years of serological surveillance in England and Wales: methods, results, implications and action. International Journal of Epidemiology 2000; 29: 362–368.
15. Vyse, AJ, et al. Interpreting serological surveys using mixture models: the seroepidemiology of measles, mumps and rubella in England and Wales at the beginning of the 21st century. Epidemiology and Infection 2006; 134: 1303–1312.
16. Vyse, AJ, et al. Seroprevalence of antibody to varicella zoster virus in England and Wales in children and young adults. Epidemiology and Infection 2004; 132: 1129–1134.
17. Nardone, A, et al. Seroepidemiology of Bordetella pertussis in England and Wales. Vaccine 2004; 22: 1314–1319.
18. Vyse, AJ, et al. The burden of Helicobacter pylori in England and Wales. Epidemiology and Infection 2002; 128: 411–417.
19. Maple, PAC, et al. Immunity to diphtheria and tetanus in England and Wales. Vaccine 2001; 19: 167–173.
20. Morris, MC, et al. The changing epidemiological pattern of hepatitis A in England and Wales. Epidemiology and Infection 2002; 128: 457–463.
21. Vyse, AJ, Hesketh, LM, Pebody, R. The burden of infection with cytomegalovirus in England and Wales: how many women are infected in pregnancy? Epidemiology and Infection. Published online: 15 September 2008. doi:10.1017/S0950268808001258.
22. Kelly, H, et al. A random cluster survey and a convenience sample give comparable estimates of immunity to vaccine preventable diseases in children of school age in Victoria, Australia. Vaccine 2002; 20: 3130–3136.
23. Gungabissoon, U, Balogun, MA, Ramsay, ME. Hepatitis C virus: laboratory surveillance in England and Wales, 1992–2004. Epidemiology and Infection 2007; 135: 541–548.
24. Balogun, MA, et al. A national survey of genitourinary medicine clinic attenders provides little evidence of sexual transmission of hepatitis C virus infection. Sexually Transmitted Infections 2003; 79: 301–306.
25. Brant, LJ, et al. Sentinel laboratory surveillance of hepatitis C antibody testing in England: understanding the epidemiology of HCV infection. Epidemiology and Infection 2007; 135: 417–426.
26. HPA. Health Protection Agency, Health Protection Scotland, National Public Health Service for Wales, CDSC Northern Ireland, CRDHB and the UASSG. Shooting up: Infections among injecting drug users in the United Kingdom 2005. London: Health Protection Agency, October 2006.
27. Sutton, AJ, et al. Modelling the characteristics of the male injecting drug user population in England and Wales. International Journal of Drug Policy 2005; 16: 176–182.
28. Sweeting, M, et al. The burden of hepatitis C in England. Journal of Viral Hepatitis 2007; 14: 570–576.
29. Hughes, G, Simms, I, Leong, G. Data from UK genitourinary medicine clinics, 2006: a mixed picture. Sexually Transmitted Infections 2007; 83: 433–435.